What Can I Try for Erectile Dysfunction Beyond Pills?

What can I try if sildenafil or tadalafil does not work?

When an oral medicine falls short, the next step is a treatment review—not an automatic jump to surgery. The American Urological Association (AUA) guideline recommends that clinicians explain how to maximize the effectiveness of oral PDE5 inhibitors and adjust the dose for optimal efficacy before concluding treatment has failed.

The review should also look beyond the prescription. The AUA recommends discussing medical, sexual, and psychosocial history, conducting a physical exam, using lab tests selectively, and measuring morning total testosterone. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) notes that clinicians may review medicines that could contribute to ED and consider a dose change or alternative. Do not stop a prescribed medicine on your own; discuss concerns with the clinician who manages it.

Health conditions matter, too. The AUA guideline says ED can be more severe at baseline, and oral medicines may work less robustly, for men with diabetes or after prostate surgery. A clinician can explain whether a device or locally delivered medicine is a reasonable alternative and whether referral to a urologist or another specialist would help. An appointment may include questions about symptoms and health history, an exam, and—depending on the situation—blood or urine tests. Mayo Clinic also describes ultrasound as one possible way to evaluate penile blood flow.

Make the visit easier to use: bring a list of medicines and note what happened when you tried the oral treatment, including whether you followed the clinician’s instructions. A clear opening line is: “The tablets have not worked as expected. Can we review how I’m using them and talk through other options?” If privacy or a partner’s concerns are part of the decision, say so. NIDDK notes that a partner may be included in treatment discussions if the patient wants that.

How does a vacuum erection device work?

A vacuum erection device uses a tube, a pump, and an elastic ring: the pump draws blood into the penis, and the ring helps maintain the erection. The equipment avoids medication taken by mouth, but it requires handling and practice.

NIDDK lists possible effects such as coldness, numbness, bruising, or weaker ejaculation. The AUA guideline also reports bruising, discomfort, difficulty ejaculating, and difficulty using the device as minor adverse effects. Those practical details can matter as much as whether the device can produce an erection: ease of setup, comfort, and the couple’s preferences all affect whether an option feels workable.

Effectiveness figures vary by source and measure. The AUA guideline cites mean patient and partner satisfaction of 77% in its referenced research. The European Association of Urology (EAU) guideline reports that vacuum devices produce erections satisfactory for intercourse in up to 90% of patients, with satisfaction estimates ranging from 27% to 94%; it also reports that efficacy with long-term use decreases to 50–64% after two years. These are findings from different evidence summaries, not a guarantee for an individual.

Ask a clinician to demonstrate the device and explain how to use it safely and comfortably. A useful question is: “Can you show me the setup and explain what problems mean I should stop and ask for help?” That turns a device discussion into a practical trial plan rather than a vague recommendation.

Are ED injections or urethral medication effective?

Yes. Injectable medicines and urethral alprostadil can help produce an erection, but they have different application steps and potential side effects. A health professional can teach the technique and help decide whether either option fits the person’s health and preferences.

With intracavernosal alprostadil, medicine is injected into the penis. The EAU guideline reports efficacy above 70% across the general ED population and in subgroups including men with diabetes or cardiovascular disease; reported patient satisfaction is 87–93.5%. The same guideline lists possible adverse effects including penile pain, prolonged unwanted erections, priapism, and fibrosis. It reports discontinuation rates of 41–68%, a reminder that effectiveness in studies does not mean every patient finds the treatment acceptable or easy to continue.

Mayo Clinic notes that self-injection can cause bleeding at the injection site, prolonged erection, and, rarely, fibrous tissue. A clinician should explain how to use the treatment and what to do if an erection lasts longer than expected. Keep the discussion specific: “What training will I get, and what symptoms require urgent contact?”

Urethral alprostadil is placed into the urethra with an applicator rather than injected. Mayo Clinic says an erection often begins within 10 minutes and lasts 30–60 minutes; burning or minor urethral bleeding can occur. These timing figures are from Mayo Clinic’s treatment information, not a promise about an individual response.

Evidence estimates for urethral treatment also differ by study. The AUA guideline describes one large cited study in which 299 of 461 men (64.9%) achieved at least one intercourse episode at home. The EAU guideline reports intercourse-sufficient erections ranging from 30% to 65.9%, and notes local pain and dizziness with possible low blood pressure among common adverse effects. The AUA advises in-office testing, dose titration, and instruction. That supervised start gives the patient and clinician a chance to assess response and technique before relying on the method at home.

There is no single best non-pill option for everyone. A device may appeal to someone who wants to avoid medication; injections or urethral medicine may be considered when a clinician judges them appropriate and the patient is comfortable with the method. Compare the steps, side effects, privacy needs, and partner preferences directly with the clinician. A related guide discusses whether sexual health supplements for men are safe or effective.